bioAffinity Technologies (BIAF) Receivables - Other (2022 - 2025)
bioAffinity Technologies (BIAF) has disclosed Receivables - Other for 4 consecutive years, with $27143.0 as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Other fell 44.82% to $27143.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $27143.0, a 44.82% decrease, with the full-year FY2024 number at $27874.0, down 5.68% from a year prior.
- Receivables - Other was $27143.0 for Q3 2025 at bioAffinity Technologies, up from $19516.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $119363.0 in Q2 2024 to a low of $4730.0 in Q3 2023.
- A 4-year average of $36138.5 and a median of $27508.5 in 2024 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: surged 940.02% in 2024, then tumbled 83.65% in 2025.
- bioAffinity Technologies' Receivables - Other stood at $10489.0 in 2022, then soared by 181.75% to $29553.0 in 2023, then fell by 5.68% to $27874.0 in 2024, then dropped by 2.62% to $27143.0 in 2025.
- Per Business Quant, the three most recent readings for BIAF's Receivables - Other are $27143.0 (Q3 2025), $19516.0 (Q2 2025), and $17381.0 (Q1 2025).